A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia

Purpose We set out to characterize the pattern of fundus autofluorescence (AF) loss in choroideremia (CHM) patients of varying ages and disease severity in order to determine the average rate of progression of this potential disease biomarker. Methods Fifty consecutive CHM patients (100 eyes) attending outpatient clinics at Oxford Eye Hospital underwent analysis with the Heidelberg OCT Spectralis with autofluorescence capabilities. The area of residual AF was traced using Heidelberg Eye Explorer. Bland-Altman analysis was used to calculate the coefficient of repeatability (CR). The degree of AF loss was correlated to different ages and the pattern of residual AF constructed into color-coded maps in order to gain insight into the mechanism of disease progression. Results The CR for measurement of AF area is <1%, indicating that a small change is likely to be significant. Correlation of patient age and area of residual AF produced a clinically relevant index of expected anatomic disease. Progression is 7.7% of the residual area each year (95% confidence intervals 7.0%–8.2%) and follows a logarithmic pattern with age (r = 0.95, P < 0.001). From this we derived the mean half-life of AF as 9 years. Qualitatively, the pattern of remaining AF centered on a point temporal to the fovea. Conclusions The area of residual AF in CHM can be measured reproducibly and shows a distinct pattern of loss. The measured residual area is inversely correlated to age. The ratio of the two variables may provide useful information regarding the rate of progression for any one individual at a given point in time.

[1]  R. MacLaren,et al.  Correlation of retinal structure and function in choroideremia carriers. , 2015, Ophthalmology.

[2]  R. MacLaren,et al.  Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia. , 2010, Investigative ophthalmology & visual science.

[3]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[4]  A. Bird,et al.  Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. , 2004, American journal of ophthalmology.

[5]  R. Fimmers,et al.  The "diffuse-trickling" fundus autofluorescence phenotype in geographic atrophy. , 2014, Investigative ophthalmology & visual science.

[6]  C K Dorey,et al.  Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. , 2001, Investigative ophthalmology & visual science.

[7]  N. Yoshimura,et al.  Wide-field fundus autofluorescence abnormalities and visual function in patients with cone and cone-rod dystrophies. , 2014, Investigative ophthalmology & visual science.

[8]  D. S. Mcleod,et al.  High-resolution histologic analysis of the human choroidal vasculature. , 1994, Investigative ophthalmology & visual science.

[9]  Atul K. Jain,et al.  Ultra-wide-field and autofluorescence imaging of choroidal dystrophies. , 2010, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[10]  F. Delori,et al.  Optimization of in vivo confocal autofluorescence imaging of the ocular fundus in mice and its application to models of human retinal degeneration. , 2012, Investigative ophthalmology & visual science.

[11]  I. MacDonald,et al.  Analysis of a large choroideremia dataset does not suggest a preference for inclusion of certain genotypes in future trials of gene therapy , 2016, Molecular genetics & genomic medicine.

[12]  M. Tso,et al.  Angioarchitecture of the human choroid. , 1987, Archives of ophthalmology.

[13]  Russell L Woods,et al.  Quantitative fundus autofluorescence in recessive Stargardt disease. , 2014, Investigative ophthalmology & visual science.

[14]  G. Holder,et al.  Visual Acuity after Retinal Gene Therapy for Choroideremia. , 2016, The New England journal of medicine.

[15]  N. Yoshimura,et al.  Wide-field fundus autofluorescence imaging of retinitis pigmentosa. , 2013, Ophthalmology.

[16]  Aki Kato,et al.  Wide-field fundus autofluorescence imaging to evaluate retinal function in patients with retinitis pigmentosa. , 2014, American journal of ophthalmology.

[17]  B. Wilhelm,et al.  Multimodal assessment of choroideremia patients defines pre-treatment characteristics , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[18]  J. Duker,et al.  Choriocapillaris and Choroidal Microvasculature Imaging with Ultrahigh Speed OCT Angiography , 2013, PloS one.

[19]  F. Cremers,et al.  Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial , 2014, The Lancet.

[20]  F W Fitzke,et al.  Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. , 1995, The British journal of ophthalmology.

[21]  L. Feeney-Burns,et al.  Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. , 1984, Investigative ophthalmology & visual science.

[22]  A. Bird,et al.  FUNDUS AUTOFLUORESCENCE IMAGING: Review and Perspectives , 2008, Retina.

[23]  Russell L Woods,et al.  Quantitative fundus autofluorescence in healthy eyes. , 2013, Investigative ophthalmology & visual science.

[24]  Danielle B. Gutierrez,et al.  Quantitative autofluorescence and cell density maps of the human retinal pigment epithelium. , 2014, Investigative ophthalmology & visual science.

[25]  J. M. Sullivan,et al.  Fundus autofluorescence and photoreceptor cell rosettes in mouse models. , 2014, Investigative ophthalmology & visual science.

[26]  I. MacDonald,et al.  Choroideremia: new findings from ocular pathology and review of recent literature. , 2009, Survey of ophthalmology.